v3 Template
X

Xylyx Bio, Inc.

Biotechnology and Healthcare ~500 employees
Founded
--
Employees (Est.)
~500
25 leaders known
Total Funding
$5.8M
Funding Rounds
3
Last Funding
2025-04-02

About Xylyx Bio, Inc.

Xylyx Bio is dedicated to transforming transplant medicine by developing bioengineered human organ grafts to address the global organ shortage and save lives through increased organ availability for transplantation.

Products & Services

Inspirex™ Bioengineered Organ Grafts:Fully functional, anatomically compatible whole organ grafts for life-saving transplantation, including Inspirex™ Lung and Inspirex™ Liver.
InMatrico® Kits & Assays:Biotechnology products for research and application in matrix biotechnologies.
ExMatrico® Peptides (Matrikynes®):Peptides used in matrix biotechnologies for various biological applications.

Specialties

Bioengineered Human Organ Grafts Transplant Medicine Matrix Biotechnologies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant 		A: 1125000
MR: -
FA: 1.125 million
FAN: 1125000 		D: 2025-04-02
FD: 2025-04-02 		3 investors
2 RT: SBIR Grant
T: -
FT: SBIR Grant 		A: 2453331
MR: -
FA: $2.45M
FAN: 2453331 		D: 2024-09-16
FD: 2024-09-16 		1 investors
3 RT: SBIR Grant
T: -
FT: SBIR Grant 		A: 2265419
MR: -
FA: 2.26M
FAN: 2265419 		D: 2024-06-14
FD: 2024-06-14 		1 investors
Grant Latest
2025-04-02
$1.1M
3 investors (Pro only)
SBIR Grant 2024-09-16
$2.5M
SBIR Grant 2024-06-14
$2.3M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

A

Andrea Nye

Chief Executive Officer, President, Board Director

LinkedIn (Pro only)
J

John O'Neill

Chief Scientific Officer, Co-Founder, Board Director

LinkedIn (Pro only)
A

Anthony Curro

Board Chair & Interim Chief Financial Officer

LinkedIn (Pro only)
E

Evelyn Aranda

Director of Applications

M

Matthew Bacchetta

Scientific Advisor | Lung Transplantation, Vanderbilt University Medical Center

M

Matthew D. Bacchetta

Professor of Cardiac Surgery, Thoracic Surgery, and Biomedical Engineering

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

Xylyx Bio, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology and Healthcare
Company Size
~500 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro